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Abstract 
 
Identification of genetic origin in bilateral breast cancer 
 
 
 
 
Seo Min Young 
Department of Medical Science 
 The Graduate School, Yonsei University 
<Directed by Professor Chung Hyun Cheol> 
 
Bilateral breast cancer (BBC) can be divided into two groups; 
synchronous and metachronous cancer. In case of both 
metachronous and synchronous tumors, it remains unclear whether 
the BBC represents the coincidental occurrence of two independent 
primary cancers or concurrently identified metastasized tumor 
from contralateral breast cancer. In later case, two tumors are 
considered to be of same genetic origin. Understanding about the 
genetic origin of BBC is very important for prognosis prediction 
and proper treatment.  
In this study, we employed two different technologies in order to 
assess genetic and epigenetic changes in tumor, which allow us to 
 ２
determine the genetic characterization of BBC. At first, results from 
X-chromosome inactivation assay were unable to indicate their 
genetic origin in bilateral breast cancer. There were some 
limitations of using X chromosome assay for clinical application in 
bilateral breast cancer patients. Because of tumor heterogeneity, 
one marker located on the X chromosome was insufficient for 
comparing cancer origin in bilateral breast cancer. 
Thus, array based CGH pattern analysis was utilized to identify 
genomic origin in BBC. To evaluate the specificity of the hybridized 
spot signal on array CGH chip and experimental bias from dye 
labeling efficiency, we performed homotypic experiment, dye 
swapping test, and the hybridization with known DNA control 
spikes. We confirmed that our array-based CGH system specifically 
recapitulated the genomic changes in target preparation. Different 
genomic DNA changes were 2%±2.20 in synchronous pairs, whereas 
the changes were 14.3%±10.6 in metachronous pairs.  
In conclusion, our results suggested that bilateral breast cancers 
which originated from different clones have different chromosomal 
imbalance patterns. The array based-CGH is considered as a useful 
tool for direct detection of genome profiles.  
 ３
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: Genetic Origin, Bilateral Breast Cancer (BBC), X-
Chromosome Inactivation Pattern Analysis (XCIP), Array-based 
Comparative Genomic DNA Hybridization (CGH) 
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Ⅰ. INTRODUCTION 
Tumor metastasis is the major cause of cancer morbidity and 
mortality. As metastatic cancer cells represent more aggressive 
behavior and resistant to treatment, metastases cause the major 
clinical problems in the management of cancer patients. Accordingly, 
it is very important to define the tumor stage whether the tumor is a 
primary tumor or metastasized from other primary lesion in order to 
predict the exact prognosis and provide the optimal treatment to the 
cancer patient. 
One remarkable feature of tumor is the heterogeneity of their 
constituent cells. Even though there is some debate whether all or a 
limited number of cells in primary tumor have metastatic potential, it 
 ５
is clear that individual metastasis originates from a single cell, i.e. 
one clonal origin and that different metastases can arise from 
different parent cells. Because metastatic lesions are rarely surgically 
removed or biopsied, it is hard to evaluate the changes of biomarker 
during the metastatic progression. 
Bilateral breast cancer (BBC) can be divided into two groups; 
synchronous, in which both tumors occur simultaneously, or 
metachronous, in which the tumors appear at different points. In 
case of both metachronous and synchronous tumors, it remains 
unclear whether the BBC represents the coincidental occurrence of 
two independent primary cancers or concurrently identified 
metastasized tumor from contra-lateral breast cancer. In later case, 
two tumors are considered to be of same genetic origin1. The 
empirical criteria based on the clinical parameter has been used to 
compare the characterization of two tumors in metachronous and 
synchronous cancer2, 3. The criteria includes; 1) differentiation grade, 
2) presence of ductal carcinoma in situ (DCIS), and 3) systemic 
metastasis to another organs.   
  To identify the characteristics of the various breast cancers 
clinically, the detection of histological phenotypes such as estrogen 
 ６
receptor(ER), progesterone receptor(PgR) or c-erbB2 has been used4. 
On the other hand, the differential methylation status in certain X 
chromosomal genes in females is suggested as a possible molecular 
approach5. 
 The inactivation of one of the two X chromosomes occurs early in 
development. This process resulted in individuals having cellular 
mosaics with either the maternal or paternal X chromosome 
inactivated. Dosage compensation in humans is achieved through the 
random inactivation of X chromosome. The inactivation of one X-
chromosome with concomitant methylation of the 5 end of genes, 
such as phosphoglycerate kinase(PGK) gene, hypoxanthine 
phosphoribosyltransferase(HPRT) gene, or human androgen 
receptor (HUMARA) gene provides a stably inherited genetic 
marker6,7,8. However, there are some limitations of using X 
chromosome assay for clinical application in bilateral breast cancer 
patients. Even though the methylation of different X alleles 
represents absolute evidence of independent tumorigenic processes, 
the opposite situation with the methylation of the same allele, has 
little meaning with following reasons9. First, because of tumor 
heterogeneity, one marker dependent on the X chromosome is 
 ７
insufficient for comparing genetic origin. Second, this assay is 
applicable only to female. Therefore, a supplementary solution is 
needed to complement the X chromosome inactivation assay.  
  The characterization of gene copy number changes and gene 
expression patterns provide a basis for investigating the pathogenic 
mechanisms involved in tumor promotion and metastasis. Especially, 
the information about chromosomal imbalances, such as deletion and 
amplification, gives us the significant clue to understand malignant 
behavior of cancer cells. Moreover, individual tumor from the same 
genetic origin will represent similar patterns in this respect. The 
DNA microarray technique can be used to monitor many genes at 
transcription level, simultaneously. Array-based comparative 
genomic DNA hybridization (CGH) has demonstrated a certain 
comparative ability in terms of DNA copy-number changes with 
higher sensitivity and resolution capacity compared to the 
conventional CGH10. This suggests the possibility of using array-
based CGH for tumor origin comparison. 
In this study, we employed two different technologies in order to 
assess genetic and epigenetic changes in tumor, which allow us to 
compare the genetic origin of metachronous and synchronous 
 ８
bilateral breast cancers. Our results suggest that bilateral breast 
cancers, which originated from different cell, have different 
chromosomal imbalance patterns. Array-based CGH is seemed to be 
an useful tool for the direct genetic profiling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ９
Ⅱ. MATERIALS AND METHODS 
    The scheme of the whole study is outlined in Figure1.  
1. Tissue specimens. 
Eighteen pairs of bilateral breast cancer tissues were obtained as 
paraffin embedded tissue blocks from biopsy or surgical resection 
specimens at the Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea. Actual experiment sample sizes are showed 
in Table 1. Pathologist confirmed the diagnosis and tumor areas by 
hematoxylin and eosin (H&E) stained slide. Tumor samples with 
high normal cell contents (more than 30% of tissue area) were 
excluded from the study. 
When two breast tumors were detected with the interval of more 
than one year, we defined it as a metachronous tumor.  
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Fig.1 . Scheme of the study. A. X-chromosome inactivation pattern 
analysis. B. cDNA microarray based CGH pattern analysis. 
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Table 1. The scale of the study
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2. X-chromosome inactivation analysis.  
The status of activation of the X-chromosome in synchronous 
tumor and metachronous tumor cases was determined by using 
methylation - sensitive restriction enzymes, HhaI. A 280bp PCR 
amplification unit including the flanking HhaⅠsites and 
trinucleotide repeat element (nucleotides 229-508, HUMARA; 
Genebank) was desiginated for the human androgen receptor locus4. 
When the template DNA was digested with methylation sensitive 
restriction enzyme, the PCR amplification only occurred where the 
restriction sites had been methylated; otherwise, if any of the 
restriction sites were unmethylated, then amplification could not be 
successful due to the digestion with the flanking oligonucleotides 
binding region. 
A. Cell culture 
As a control for enzyme digestion and PCR, we used the YCC-2, 
YCC-6 gastric cancer cell lines which were established from the 
ascites of gastric cancer patients (Yonsei Cancer Center, Seoul, 
Korea). The cells were cultured and maintained  in MEM with 
10% fetal bovine serum (GIBCO, Grand Island, NY, USA), in 100 
units/ml of penicillin and 0.1mg/ml of streptomycin (GIBCO, Grand 
Island, NY, USA) at 37℃, in a 5% CO2 incubator. 
B. Genomic DNA extraction 
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Dissected tissues from paraffin blocks, fresh frozen tissues and 
the cultured cells were incubated with 400ul of DNA lysis buffer 
[10mM Tris PH7.6, 10Mm EDTA, 50Mm NaCl, 0.2%SDS, 200ug/ml 
Proteinase K] at 42℃ for 12-24hours. The incubated products were 
boiled for 10 mins at 100℃ to inactivate enzymatic activity, and 
then treated with the same amount of phenol / chloroform / 
isoamylalcohol (GIBCO-BRL, Gaithersburg, MD, USA) to isolate 
the nucleic acid from the proteins. DNA was precipitated with 100% 
ethyl alcohol containing 1/3 volume of 10M ammonium acetate and 
2ul of glycogen. After being rinsed with 70% ethyl alcohol, the DNA 
was dried at room temperature and then dissolved in ultra-pure 
water. DNA concentrations were determined using UV 
spectrophotometer at 260nm and DNA was stored at -20℃ until the 
experiment.  
C. Enzyme digestion  
For each DNA sample, two reactions were conducted 
simultaneously. One microgram of genomic DNA was digested with 
20units HhaⅠ(Promega, Madison, WI, USA), and another 1ug of 
DNA was incubated in enzyme buffer without HhaⅠenzyme. All 
reactions were conducted in a total volume of 20ul, and then 
incubated for 8-12h at 37℃. After the digestion, the reactions were 
terminated by boiling at 95℃ for 10 mins.  
D. HUMARA-PCR assay13 
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 Three micro liters of previous enzyme digested DNA was added 
to 30ul of the PCR mixture containing two oligonucleotide primers 
(Genotech, Daejun, Korea) at a concentration of 20 pmole, 250uM 
dNTPs (GIBCO-BRL, Gaithersburg, MD, USA), 0.5U Taq 
polymerase (GIBCO-BRL, Gaithersburg, MD, USA), 2.5mM 
MgCl2 , α-32P dCTP and 3ul DMSO. The primers sequences were 
obtained from the previous report: primer 1, 5--
GCTGTGAAGGTTGCTGTTC-CTCAT--3 and primer 2, 5--
TCCAGAATCTGTTCCAGAGCGTGC--3 (Tilley et al. 1989). 
Samples were amplified for 28 cycles (45s at 95℃, 30s at 60℃ and 
30s at 72℃) after the initial denaturation at 95℃ for 3mins in a 
thermocycler (MWG AGbiotech, Germany). Five micro liters of the 
PCR product was mixed with 5ul of 2X gel-loading buffer, and then 
the mixture was loaded into 6% 39:1 acrylamide / bis-acrylamide 
gel.  Electrophoresis was performed at 80W for 3 hours. The gel 
was then dried and exposed to X-ray film (Kodak) at -70℃ for 12 
hours using an intensifying screen. The gel was also stained with 
ethidium bromide and visualized under UV or stained with 0.1% 
silver nitrate.   
 
3. cDNA microarray based genomic DNA hybridization. 
A. cDNA microarray and control clones 
Human cDNA microarrays (Genomic Tree Co, Daejun, Korea) 
containing sequence verified 974 genes were used. As spike 
 15
controls, 9 human cDNA clones were amplified using universal 
primer ; AI086446, AA903183, AI459073, AA490996, AA465697, 
AA457034, AA459263, AA28115 (Genebank ID).     
B. Labeling and hybridization 
The same genomic DNA used for the X chromosome inactivation 
assay were used as the test and reference samples. For each 
fluorescent labeling, we used 4ug of digested genomic DNA with 
DpnⅡ (New England Biolabs, Beverly, MA, USA), which was then 
purified QIAquick PCR purification kit (QIAgen, Dusseldorf, 
Germany). In case of the DNA from paraffin embedded tissues, 
fragmentation was not needed because it had already degraded 
(Fig.2). Fragmented DNA was random-primer labeled using a 
Bioprime Labeling kit (GIBCO-BRL, Gaithersburg, MD, USA). We 
modified the method8 to allow a 50ul reaction, 10x low dCTP-dNTP 
mix (containing of 1.2mM each dATP, dGTP, dTTP and 0.6mM of 
dCTP; GIBCO-BRL, Gaithersburg, MD, USA) and Cy5-dCTP or 
Cy3-dCTP (0.6Mm ; DuPont NEN Life Sciences, Boston, MA, USA). 
The reactions mixtures were incubated at 37℃ for 2 hours in dark 
space. The reaction was stopped by adding 5ul of 0.5 M EDTA, 
pH8.0.  
Pre-hybridization was performed with the blocking solution 
consisted of 3.5X SSC, 0.1% SDS, 10mg/ml BSA and dH2O. The 
solution was filtered and incubated at 42℃ or 50℃ for 30 min-1 
hour. The spotted slides were dipped in water and in isopropanol 
serially and then completely dried at 1000 rpm for 5mins.  
 16
Cy5- and Cy3- labeled probes were mixed with 30ug human Cot-
1 DNA (GIBCO-BRL, Gaithersburg, MD, USA), 20ug poly (dA)-
poly (dT) (Sigma, Saint Louis, Missouri, USA), and 100ug yeast 
tRNA (GIBCO-BRL, Gaithersburg, MD, USA). A Microcon-30 
filter (Amicon, Bedford, MA, USA) was used to purify and 
concentrate the hybridization mixture, which was then adjusted to 
contain 3.4X SSC and 0.3% SDS in a final volume of 40ul. Following 
denaturation at 100℃ for 1.5 mins and a 30 mins of pre-annealing 
at 37℃, the probe was hybridized to the array under a glass 
coverslip at 65℃ for 24-30 hours. The probe was then washed in 
washing solutions with 0.5X SSC-0.01% SDS, 0.06X SSC-0.01% 
SDS, and 0.05X SSC three times at room temperature and dried by 
centrifugation at 1000rpm for 5 mins. 
    C. Imaging and data analysis 
Hybridized arrays were scanned using a GenePix 4000B (Axon 
Instruments, USA) and fluorescence signals were calculated after 
subtracting the background by GenePix Pro 4.0(Axon Inc.USA).        
Poor feature signals ( F532 nm-1.5 X B532 nm < 0 , F635nm-1.5 X 
B635nm < 0 ) were filtered out as flagging. An MA-plot12 was used 
to represent the (R, G) data, where M=log2R/G and A= log2(R x 
G)1/2 ; R means F635 signal from Cy-5 and G means F532 signal 
from Cy-3 labeling. With MA-plots, we identified spot artifacts and 
detected intensity  dependent patterns in M for the purpose of 
normalization (Fig.3). To correct the differences originated from 
inter-sample DNA-labeling efficiency, a withinpin tip group 
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normalization was performed14. A raw data was simply normalized 
relative to a (pin tip+A), 
i.e. log2R/G → log2R/G-ci(A)= log2R/[ki(A)G] 
where ci(A) is the Lowess fit14 to the MA-plot for the ith pin group 
only,i=1,2,.I, and I denotes the number of pin groups. 
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Fig. 2. Genomic DNAs. The left is genomic 
DNA from fresh frozen tissue and the right 
is genomic DNA from paraffin embedded 
tissue. 
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Ⅲ. RESULTS 
1. X-chromosome inactivation pattern analysis (XCIP) 
XCIP was performed by using HUMARA-PCR assays, to 
determine the genetic origins in BBCs. We exploited XCIP analysis 
with 15 pairs of bilateral breast cancer specimen. We had expected 
different amplification pattern of HUMARA gene with one or two 
bands in BBC from different cancer origin (Fig.4). On the other side, 
in case of the pair of breast tumors originated from same clone, the 
band pattern would have been same5, 6. As a positive control for 
enzyme digestion and PCR, gastric cancer cell lines were tested for 
XCIP analysis. In case of the cell line from man, there were one 
allele, and the allele was disappeared after the enzyme digestion. 
Another cell line from woman, the band pattern was same as in 
BBC. We could evaluate the XCIP of gastric cancer tumor with 
ometum and lymph node metastasis from one patient. All of the 
three cases showed the same band pattern (Fig.5A). According to 
our XCIP results, there was a consistent pattern with paired 
samples regardless of their BBC type. Among five pairs of 
metachronous and ten pairs of synchronous tumors, each case 
showed the same band patterns in two comparative tissues (Fig. 5). 
This fact suggests that the XCIP analysis is not enough to discern 
the genetic origin of tumors in BBC with our small cases. Therefore, 
we then decided to perform a further analysis using array-based 
comparative genome hybridization (CGH). 
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_
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 Bilateral breast cancer  patient A   
Fig4. Expected amplification patterns of HUMARA 
gene in the pair of bilateral breast cancer. 
 22
 
 
Fig.5. X-chromosome inactivation pattern analysis in bilateral breast cancer A. 
stomach cancer with omentum and lymph node metastasis; B. metachronous 
bilateral breast cancer ; C. synchronous bilateral breast cancer. (First number 
indicates the year when the tumor was procured. LN-lymph node Rt-right breast 
cancer Lt-left breast cancer.
B.     92-Lt          94-Rt 92-Lt            99-Rt 
 C.        00-LN1                00-Lt                    00-Rt 
A.        97-omentum         97-lymph node            97-stomach  
          98-Rt                98-Lt 
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2. cDNA microarray-based comparative genomic DNA 
hybridization pattern analysis. 
We compared genome-wide differences between individual 
tumors in BBC utilizing hybridization of the total genomic DNA 
onto cDNA microarrays. Data analysis was proceed after filtering 
and performing within-pin tip group normalization (Fig.3 and 
Fig.6).   
At first, we confirmed the systematic reliability of CGH 
technique that we employed by doing the homotypic hybridization 
test using the same DNA labeled with cy3 or cy5 (Fig.7). When two 
different dyes were labeled with same DNA source and hybridized 
together, the average log ratio after homotypic hybridization was 
0.0005 indicating no bias in our condition of the hybridization.  
To evaluate the specificity of the hybridized spot signal on array-
based CGH chip and to evaluate the experimental bias from dye 
labeling efficiency, samples from synchronous case was tested in dye 
swapping method (Fig.7). The genomic DNA from left breast tissue 
of one patient was labeled with cy3 and from right breast tissue of 
same patient was with cy5 and then reverse labeling was performed. 
An average log ratio for all spots in dye swapping test was 0.0028. 
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Fig.7.  Pseudocolour image of cDNA microarray hybridization of spikes 
control to confirm the specificity. A: Homotypic experiment. DNA of 
left breast tumor was labeled with Cy3 and Cy5 B: DNA from the left 
breast cancer was labeled with Cy3 and known DNA fragment which 
was amplified was labeled with Cy5. 
B. Amplified clones AA490996
AA457034  :50ng 
AI459073  :116ng 
AA465697  :290ng 
AA281152  :879ng 
A.Homotypic experiment 
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Next, to evaluate whether the array-based CGH system 
recapitulate the changes of gene copy number, various amount of 
synthetic PCR products representing probes on array were 
exogenously added to hybridization targets. In figure 8, sample used 
in homotypic reaction was labeled with cy3 and amplified PCR 
products were labeled with cy5. We observed that 5 out of 9 
exogenously introduced DNA fragments expressed significant 
signals on each spot (Fig. 8).  
We tested genetic patterns of lymphocytes from two different 
patients. We assumed that, even in different individuals, most of the 
genomic DNA copy number for each gene must be quite similar to 
each other in healthy physiological condition. We observed that only 
0.5% of genes out of 600 probes on array showed different DNA 
copy number. This result indicated that the expressions of certain 
genes are regulated at transcription and/or post-transcriptional 
level (Fig. 9). 
In one hybridization assay with different type of tumor 
originated from the same patient (stomach vs colon cancer), notable 
log ratio values were observed in 28% of the spots in genomic DNA 
level suggesting that two samples showed significantly different 
genetic profiles (Fig. 10). 
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Fig.8. Synchronous bilateral breast cancer. A. Homotypic experiment. left 
breast tumor tissue was labeled with both Cy3 and Cy5. B. right breast 
tissue was labeled with Cy3 and left was labeled with Cy5. C .dye swapping
interleukin 2 receptor, beta  
 
 
retinoblastoma-binding protein
 
 
glutathione S-
A B C
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Fig.9. The comparison of genomic DNA from the lymphocyte of 
two different patients. Genes with different DNA copy number 
(over or under a log ratios were 0.5) are less than 0.5%. 
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Fig.10. Comparison of the genetic patterns between stomach 
cancer and colon cancer in one patient. It can be used positive 
control. (cy3-stomach cancer vs. cy5-colon cancer tissue) 
It was validated by dye swapping tests.  
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We hybridized three pairs of synchronous tumors and fours 
pairs of metachronous tumors, respectively (Fig. 6, 11, 12, 13). 
Genomic DNA from one pair of three synchronous cases and two 
pairs out of four metachronous cases were used in both array-based 
CGH and XCIP analysis. Only one out of three synchronous cases, 
which did not show any different pattern in XCIP analysis, showed 
4.2% meaningful log ratio pattern changes. But rests of them were 
close to 0 suggesting that two tumors had similar genetic profiles at 
the genomic DNA level (Fig. 6, 11, 12).  
As expected, metachronous tumors were found to have more 
genes with copy number changes than synchronous tumor (Fig. 12, 
13). This finding was similar to the previous result with 2 different 
tumor types in one patient (Fig. 14). Figure 14 represented 
significant pattern of genomic DNA changes between the 
metachronous and synchronous tumor in BBC. While the average 
log ratio values of the different genomic DNA change were 2% in 
synchronous pairs, it was 14.3% in metachronous pairs. 
 In two metachronous cases Thirty-nine genes changed had high 
log ratio values. The expression of constantly genes was 
simultaneously altered in all of the three metachronous BBCs (Table 
2). These genes would be tumor progression related genes in breast 
cancer18, 20. Figure15 represents the chromosomal regions of altered 
8 genes in metachronous tumors.  
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Fig.11. Comparison of the pattern analysis in synchronous BBC using the array  
based CGH  and  X chromosome inactivation assay. A.  X-chromosome 
inactivation  
pattern is similar in this BBC case. B. 99-Lt waslabeled with Cy3 and 99-Rt was  
labeled with Cy5. The result shows 4.2% meaningful genes with high log ratio  
values of the all spots. 
A B 
    99-Lt                  
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A1-00-Lt       A2-00-Lt      A3-00-Lt       89-Rt 
A
B. 
       Fig.12. Pattern analysis in synchronous and metachronous cancer with the array 
based CGH  and  X chromosome inactivation assay. A. Left : A2-00-Lt was 
labeled with Cy3 and A3-00-Lt  was labeled with Cy5  Right : A2-00-Lt was 
labeled with Cy3 and 89-Rt was labeled with Cy5  B.  X-chromosome 
inactivation pattern is similar. The HUMARA gene is homozygous in the samples. 
A1,A2,A3 were multi-focal tumors in left breast cancer. 
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Fig.13.  A. 94-Left (Cy3)  98-Rt (Cy5)   B. The pattern of X chromosome 
 
     inactivation in same individual with A. C. 01-Rt (Cy3) 96-Lt (Cy5) 
A C
B 
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Fig.14.  Differences of the altered genes in BBC.  
H:Homotypic hybridization, S:synchronous, M:metachronous, S1-S3:
3synchronous BBCs, S:average of S1,S2 and S3, M1-M3: 3metachronous 
BBCs, M:average of M1,M2 and M3, P: altered genes in 2 different tumor types.
The differences of gene imbalances 
0%
4.20% 1.90% 0% 2%
24.90% 
3.50% 
14.40% 14.27% 
28%
0% 
20% 
40% 
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H S 1 S 2 S 3 S M 1 M 2 M 3 M P
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Table 2. Genes of high log ratio values in three 
metachronous  
cases simultaneously. 
AA775355 X-ray repair complement
AI884731 wingless-type MMTV integration 
AA496438 retinoic acid receptor, gamma
AA464217 quiescin Q6 
AA480859 pleckstrin homology, Sec7 and c
H15574 erythropoietin receptor
R07167 cystathionase (cystathionine )
AA644088 cathepsin C 
IDName 
Fig.15. Chromosomal region of the simultaneously changed 
genes in 3 metachronous cases in table2.  
 36
Ⅳ. DISCUSSION  
Understanding of the clonality of BBC is very important for 
prognosis prediction and proper treatment. However, using current 
knowledge, the phenotypic features of BBC are hard to differentiate 
them in clinically or biologically. Empirically determined diagnostic 
criteria have been proposed for the discrimination of multiple 
primary and metastatic bilateral lesions. Although it is clinically 
accepted that BBC was originated from two clonally independent 
primary malignancies, molecular or genetic approaches to discern this 
clonal issues have not been accumulated enough to make any 
conclusion so far. 
The inactivation of one of the two X chromosomes occurs early 
during development. This phenomenon resulted in individuals with 
cellular mosaics with either the maternal or paternal X chromosome 
inactivated7, 11. On the contrary to this, tumors from single cell origin 
have only one type of inactivated X chromosome. When the template 
DNA was digested with methylation sensitive restriction enzyme, the 
HUMARA PCR amplification only occurred where the restriction 
sites had been methylated; otherwise, if any of the restriction sites 
were unmethylated, then amplification could not successful due to the 
digestion with the flanking oligonucleotide binding region8. This 
concept could be applied to determine whether the tumor was 
originated from the same or different locus in BBC5, 6.  
In our case, the XCIP analysis was not informative in terms of 
discrimination of genetic origin for both synchronous and 
metachronous tumors. Thus, limited conclusions could be drawn from 
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our data, which implied the limitations of the X chromosome 
inactivation assay for the genetic characterization as we concerned. 
Since X chromosome inactivation occurs only one allele either from 
father side or mother side by selective DNA methylation, and selected 
X chromosome is inherited to daughter cells when they divide, it is 
possible that the same allele could be methylated in tumors developed 
from different clones. Consequently, the pattern analysis by XCIP 
may give us inaccurate information about the genetic origin of 
cancer11. Furthermore, the success of this test depends on the 
heterozygosity of the X-linked marker analyzed. It has been found 
that its significance may be blurred by the occurrence of an allelic 
imbalance at the X chromosome in breast tumor16, 17. The other point 
is the same pattern in a tumor may not be solely interpreted that the 
tumor was originated from one cell population. Indeed, single cell 
clone, or small number of cells, fortuitously inactivated at the same 
loci of X chromosome may outgrow during the process of neoplasia. It 
is also ambiguous to make a decision using this X chromosome pattern 
analysis due to increasing reports regarding the widespread 
methylation instability in cancer genome11. In addition, the amount 
and quality of DNA extracted from the archived tissues may influence 
on our results. 
Gene amplification is one of the major mechanisms of oncogene 
activation in tumorigenesis. On the other hand, inactivation of tumor 
suppressor genes by loss of heterozygocity (LOH), CpG island 
methylation is also important genetic and epigenetic mechanism of 
tumorigenesis. With the development of the technique of CGH onto 
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microarrayed cDNA clones12, 13, it provides us more high-through 
powerful analyses for identifying and mapping the altered genes, 
which are assumed as highly disease-related genes. This approach is 
particularly attractive because of the availability of thousands of 
accurately mapped cDNA 18, 19. Our results showed that the array-
based CGH could potentially be used as a comparative analysis tool 
for genetic characterization in tumors when their originality is not 
clear as in bilateral breast cancers.  
To confirm this modified new techniques, we performed the five 
basic experiments (Fig. 7, 8, 9, 10). When homotypic experiment was 
performed, theoretically we must have the same signal intensity after 
hybridization for each annotated DNA probe. Therefore, an average 
log ratio of signal intensity (log2Cy5/Cy3) should be zero, which means 
the tested DNA copy number was same. If the range is out of 
acceptable range (0±0.5), then we may suspect that the array 
hybridization results had a dye bias or experimental errors (Fig. 7). 
In figure 8, we showed the specificity of the hybridization using 9 
amplified spikes. As we expected, the spiked DNA yielded very strong 
intensity, whereas genomic DNA level in counterpart (cy3) displayed 
same pattern with previous experiments. Thus, this result suggested 
that our array-based CGH system can specifically recapitulate the 
genomic changes in target preparation. Although we expected that all 
of the 9 spikes express significant signals, five of nine amplified clones 
expressed the specific signal. Since we used the mixture with various 
diluted amounts of the test spike DNAs to total amounts of 2ug, one 
clone was too small to cover the while diluted spots. We also figured 
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out that the rest 3 clones had lots of restriction sites for the enzyme 
DpnII and were fragmented in silico experiments simulating enzyme 
digestion (http://tools.neb.com/NEBcutter). These fragments might 
produce nonspecific signals.  
Taken together with these results, although XCIP analysis did not 
provide enough information for genetic origin analysis in bilateral 
breast cancer, genetic profiling using array-based CGH supports the 
informative evidence to find difference of the genetic origin in tumors. 
Our results indicated that synchronous tumors presenting with highly 
concordant genetic profiles may correspond to contralateral 
metastasis. On the other hand, metachronous tumors exhibiting 
different patterns can be the secondary primary tumor. A similar 
pattern with additional abnormalities may fit the model of metastatic 
origin24. However, for clinical application, these should be investigated 
further by using more large scale approaches.  
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Ⅴ. CONCLUSION 
Studies based on X chromosome inactivation produced partial 
information about the evidence of the genetic origin of selected 
bilateral breast cancer cases. We have demonstrated that the cDNA 
array-based CGH approach presented here could be a useful tool for 
detecting the genetic origin in tumors by comparing chromosomal 
abnormality patterns, and thus discern the genetic origin in case of 
bilateral breast cancer. 
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